811 pSG5L HA PTEN C124S Citations (7)
Originally described in: Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR Proc Natl Acad Sci U S A. 1999 Mar 2. 96(5):2110-5. PubMed Journal
Articles Citing 811 pSG5L HA PTEN C124S
| Articles |
|---|
| A new role for PTEN in regulating transient receptor potential canonical channel 6-mediated Ca2+ entry, endothelial permeability, and angiogenesis. Kini V, Chavez A, Mehta D. J Biol Chem. 2010 Oct 22;285(43):33082-91. doi: 10.1074/jbc.M110.142034. Epub 2010 Aug 12. PubMed |
| Inhibition of U6 snRNA Transcription by PTEN. Cabarcas S, Watabe K, Schramm L. Online J Biol Sci. 2010 Sep 30;10(3):114-125. PubMed |
| Increased concentrations of fructose 2,6-bisphosphate contribute to the Warburg effect in phosphatase and tensin homolog (PTEN)-deficient cells. Cordero-Espinoza L, Hagen T. J Biol Chem. 2013 Dec 13;288(50):36020-8. doi: 10.1074/jbc.M113.510289. Epub 2013 Oct 29. PubMed |
| Discovery and functional characterization of a neomorphic PTEN mutation. Costa HA, Leitner MG, Sos ML, Mavrantoni A, Rychkova A, Johnson JR, Newton BW, Yee MC, De La Vega FM, Ford JM, Krogan NJ, Shokat KM, Oliver D, Halaszovich CR, Bustamante CD. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13976-81. doi: 10.1073/pnas.1422504112. Epub 2015 Oct 26. PubMed |
| Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes. van Ree JH, Nam HJ, Jeganathan KB, Kanakkanthara A, van Deursen JM. Nat Cell Biol. 2016 Jul;18(7):814-21. doi: 10.1038/ncb3369. Epub 2016 May 30. PubMed |
| PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer. Malaney P, Palumbo E, Semidey-Hurtado J, Hardee J, Stanford K, Kathiriya JJ, Patel D, Tian Z, Allen-Gipson D, Dave V. Cell Cycle. 2017 Nov 6:0. doi: 10.1080/15384101.2017.1388970. PubMed |
| PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer. Wozniak DJ, Kajdacsy-Balla A, Macias V, Ball-Kell S, Zenner ML, Bie W, Tyner AL. Nat Commun. 2017 Nov 15;8(1):1508. doi: 10.1038/s41467-017-01574-5. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.